4processed
Form 4 — Insider Transaction
GYRE THERAPEUTICS, INC.(GYRE)
Filing Date
May 22, 2026
Accepted
May 22, 2026
Accession No.
0001140361-26-022980
CIK
0001124105
Insider Transactions
| Insider | Title | Type | Shares | Price | Value | Owned After | Security | Date |
|---|---|---|---|---|---|---|---|---|
| Ye Weiguo | Chief Operating Officer | Other | 4.0K | $0 | — | 897.4K | Stock Option (Right to Buy) | May 26, 2026 |
| Ye Weiguo | Chief Operating Officer | Other | 3.5K | $0 | — | 901.4K | Stock Option (Right to Buy) | May 22, 2026 |
| Ye Weiguo | Chief Operating Officer | Other | 4.0K | $6.1 | — | 700.0K | Common Stock | May 26, 2026 |
| Ye Weiguo | Chief Operating Officer | Other | 4.0K | $0.75 | — | 704.0K | Common Stock | May 26, 2026 |
| Ye Weiguo | Chief Operating Officer | Other | 3.5K | $6.08 | — | 700.0K | Common Stock | May 22, 2026 |
| Ye Weiguo | Chief Operating Officer | Other | 3.5K | $0.75 | — | 703.5K | Common Stock | May 22, 2026 |